Performance analysis of Sunshine Biopharma (SBFM)
Annual Return
Over the past 3 years, SBFM has had an average annual return of -91.33%, underperforming the benchmark SPY, which returned +22.77% annual.
Over the past 5 years, SBFM has had an average annual return of -64.53%, underperforming the benchmark SPY, which returned +14% annual.
Over the past 10 years, SBFM has had an average annual return of -38.42%, underperforming the benchmark SPY, which returned +15.53% annual.
Since Oct 30, 2009, SBFM has had an average annual return of -43.82%, underperforming the benchmark SPY, which returned +14.78% annual.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0% | -99.25% | -57.73% | +993.10% | +262.50% | +700% | -87.50% | -93.22% | +195% | -68.99% | -52.57% | -81.74% |
| 2013 | 2012 | 2011 | 2010 | 2009 | |||||||
| -54.39% | +50% | -66.16% | -35.64% | +0% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | +0% | +0% | +0% | +0% | +0% | +0% | |||||||
| 2024 | -5.22% | -78.74% | +11.11% | -86.67% | -25.00% | -33.33% | -50.00% | +0% | +0% | +0% | +0% | +0% | -99.25% |
| 2023 | +92.11% | -26.77% | -18.83% | -14.36% | -2.58% | -18.87% | +2.86% | -15.87% | -25.47% | -6.33% | -3.38% | -6.29% | -57.73% |
| 2022 | -10.34% | +2,946.15% | +53.16% | +21.19% | -56.19% | -16.93% | -0% | +1.87% | -29.91% | +10.73% | -7.33% | -19.13% | +993.10% |
| 2021 | +500% | +104.17% | -39.80% | +3.39% | +65.57% | -26.73% | -25.68% | +18.18% | -18.46% | -20.75% | -30.95% | +0% | +262.50% |
| 2020 | +0% | +0% | +400% | +240% | -35.29% | -18.18% | +0% | -33.33% | +33.33% | +700% | |||
| 2019 | +12.50% | -44.44% | -20.00% | +25% | -40.00% | -33.33% | -50.00% | +0% | +0% | +0% | -87.50% | ||
| 2018 | +2.54% | -18.18% | -20.20% | -34.18% | +5.77% | +18.18% | -61.54% | +0% | -32.00% | -35.29% | -54.55% | +60% | -93.22% |
| 2017 | -32.50% | +11.11% | -16.67% | +36% | +5.88% | +258.33% | -24.03% | -8.16% | +70% | -22.22% | -18.49% | +21.65% | +195% |
Drawdown analysis of Sunshine Biopharma (SBFM)
The maximum drawdown for the SBFM was -99.99%, occurring on Jul 8, 2019. This drawdown has not yet recovered.
The current SBFM drawdown is -99.99%.
Since Oct 30, 2009 SBFM has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 4 times
- 30% or more: 5 times
- 20% or more: 5 times
- 10% or more: 5 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.99% | Aug 1, 2011 | 1967 | Jul 8, 2019 | Ongoing | Ongoing | Ongoing |
| -90.00% | Oct 19, 2010 | 68 | Jan 26, 2011 | 128 | Jul 29, 2011 | 196 |
| -50.00% | Jul 2, 2010 | 39 | Aug 27, 2010 | 26 | Oct 5, 2010 | 65 |
| -48.11% | Jan 22, 2010 | 9 | Feb 4, 2010 | 103 | Jul 2, 2010 | 112 |
| -32.77% | Oct 5, 2010 | 6 | Oct 13, 2010 | 4 | Oct 19, 2010 | 10 |